We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 10,000 results
  1. The Cyclin-dependent kinase 1: more than a cell cycle regulator

    The Cyclin-dependent kinase 1, as a serine/threonine protein kinase, is more than a cell cycle regulator as it was originally identified. During the...

    Giorgia Massacci, Livia Perfetto, Francesca Sacco in British Journal of Cancer
    Article Open access 28 October 2023
  2. Cyclin-dependent Kinase 5 and Neurodegenerative Diseases

    Neurodegenerative diseases are a group of diseases characterized by the progressive loss of neurons, including Alzheimer's disease, Parkinson's...

    Mingxue Song, Yalong Qiang, ... Fuyong Song in Molecular Neurobiology
    Article 20 February 2024
  3. Pharmacodynamics of Cyclin D1 Degradation in Ovarian Cancer Xenografts with Repeated Oral SHetA2 Dosing

    SHetA2 is a promising, orally active small molecule with anticancer properties that target heat shock proteins. In this study, we aimed to...

    Ankur Sharma, **n Liu, ... Sukyung Woo in The AAPS Journal
    Article Open access 12 December 2023
  4. Discovery of a small molecule that inhibits Bcl-3-mediated cyclin D1 expression in melanoma cells

    Molecular targeted therapy using a drug that suppresses the growth and spread of cancer cells via inhibition of a specific protein is a foundation of...

    Karunakar Saamarthy, Kristofer Ahlqvist, ... Ramin Massoumi in BMC Cancer
    Article Open access 18 January 2024
  5. Crystal structure of active CDK4-cyclin D and mechanistic basis for abemaciclib efficacy

    Despite the biological and therapeutic relevance of CDK4/6 for the treatment of HR+, HER2- advanced breast cancer, the detailed mode of action of...

    Severine Isabelle Gharbi, Laura A. Pelletier, ... Maria Jose Lallena in npj Breast Cancer
    Article Open access 29 November 2022
  6. GDNF-RET signaling and EGR1 form a positive feedback loop that promotes tamoxifen resistance via cyclin D1

    Background

    Rearranged during transfection (RET) tyrosine kinase signaling has been previously implicated in endocrine resistant breast cancer, however...

    Brooke A. Marks, Ilissa M. Pipia, ... Scott A. Coonrod in BMC Cancer
    Article Open access 10 February 2023
  7. Cyclin G2 in macrophages triggers CTL-mediated antitumor immunity and antiangiogenesis via interferon-gamma

    Background

    IFN-γ is a key mediator of tumor immunity that can induce macrophage polarization to suppress tumor growth. Cyclin G2 functions as a tumor...

    Lu Liu, **lan Gao, ... Yang Luo in Journal of Experimental & Clinical Cancer Research
    Article Open access 24 December 2022
  8. Cyclin-dependent kinase 7 (CDK7) inhibitors as a novel therapeutic strategy for different molecular types of breast cancer

    BACKGROUND

    Cyclin-dependent kinase (CDK) 7 is aberrantly overexpressed in many types of cancer and is an attractive target for cancer therapy due to...

    Xue Song, Chen Fang, ... Rui Xu in British Journal of Cancer
    Article 14 February 2024
  9. Serum/glucocorticoid-regulated kinase 1 contributes to the proliferation of varicella-zoster virus and induction of cyclin B1 expression

    In this study, we investigated the role of serum/glucocorticoid-regulated kinase 1 (SGK1) in varicella-zoster virus (VZV) replication. VZV DNA...

    Shinya Oda, Akinobu Yokoyama, ... Michiaki Nagasawa in Archives of Virology
    Article 09 May 2024
  10. Cyclin B2 impairs the p53 signaling in nasopharyngeal carcinoma

    Background

    Cyclin B2 (CCNB2), a member of the cyclin family, is an oncogene in multiple cancers, including nasopharyngeal carcinoma (NPC). However,...

    Qinsong Liu, Yong Yuan, ... Lu **n in BMC Cancer
    Article Open access 02 January 2024
  11. A review on the role of cyclin dependent kinases in cancers

    The Cyclin-dependent kinase (CDK) class of serine/threonine kinases has crucial roles in the regulation of cell cycle transition and is mainly...

    Soudeh Ghafouri-Fard, Tayyebeh Khoshbakht, ... Nader Akbari Dilmaghani in Cancer Cell International
    Article Open access 20 October 2022
  12. The E3 Ubiquitin Ligase SCF Cyclin F Promotes Sequestosome-1/p62 Insolubility and Foci Formation and is Dysregulated in ALS and FTD Pathogenesis

    Amyotrophic lateral sclerosis (ALS)- and frontotemporal dementia (FTD)-linked mutations in CCNF have been shown to cause dysregulation to protein...

    Jennilee M. Davidson, Sharlynn S. L. Wu, ... Albert Lee in Molecular Neurobiology
    Article Open access 27 May 2023
  13. Macrophages maintain mammary stem cell activity and mammary homeostasis via TNF-α-PI3K-Cdk1/Cyclin B1 axis

    Adult stem cell niche is a special environment composed of a variety stromal cells and signals, which cooperatively regulate tissue development and...

    Yu Zhou, Zi Ye, ... Cheguo Cai in npj Regenerative Medicine
    Article Open access 02 May 2023
  14. Inhibiting Cyclin B1-treated Pontine Infarction by Suppressing Proliferation of SPP1+ Microglia

    Pontine infarction is the major subtype of brainstem stroke causing severe neurological deficits. The pathophysiology and treatment of pontine...

    Ming Luo, Zhihua Qiu, ... Yongjun Jiang in Molecular Neurobiology
    Article 27 December 2022
  15. CRHBP is degraded via autophagy and exerts anti-hepatocellular carcinoma effects by reducing cyclin B2 expression and dissociating cyclin B2-CDK1 complex

    Autophagy is the predominant self-eating catabolic pathway activated in response to nutrient starvation and hypoxia within the microenvironment of...

    Zhiwei Wang, Mingxing Li, ... Tao Bai in Cancer Gene Therapy
    Article 27 January 2022
  16. Role of Cyclin-Dependent Kinase Inhibitors (CKIs) as a Prognostic Biomarker for Cancer

    Prognostic biomarkers have drawn significant attention in recent decades as a dependable, low-cost tool for not only early cancer diagnosis and...
    Md. Golam Hossain, Yearul Kabir in Handbook of Cancer and Immunology
    Living reference work entry 2022
  17. MiR-139 Affects Radioresistance in Esophageal Cancer by Targeting the PDK1/AKT/Cyclin D1 Signaling Pathway

    We explored the mechanism by which miR-139 modulates radioresistance of esophageal cancer (EC). The radioresistant cell line KYSE150R was obtained...

    Yao Liu, Yu Liu, W. P. Jiao in Bulletin of Experimental Biology and Medicine
    Article 01 February 2023
  18. Inhibition of USP10 induces myeloma cell apoptosis by promoting cyclin D3 degradation

    The cell cycle regulator cyclin D3 (CCND3) is highly expressed in multiple myeloma (MM) and it promotes MM cell proliferation. After a certain phase...

    Yu-jia Xu, Kun Zeng, ... **n-liang Mao in Acta Pharmacologica Sinica
    Article 13 April 2023
  19. The Oncogenic Role of Cyclin-Dependent Kinase Inhibitor 2C in Lower-Grade Glioma

    Lower-grade gliomas (LGGs) are slow-growing, indolent tumors that usually affect younger patients and present a therapeutic challenge due to the...

    Qiongni Zhu, Zhimin Zhu, ... Ying Guo in Journal of Molecular Neuroscience
    Article 24 May 2023
  20. Targeting cyclin-dependent kinase 9 in cancer therapy

    Cyclin-dependent kinase (CDK) 9 associates mainly with cyclin T1 and forms the positive transcription elongation factor b (p-TEFb) complex...

    Yi-li Shen, Yan-mao Wang, ... **ao-ying Huang in Acta Pharmacologica Sinica
    Article 22 November 2021
Did you find what you were looking for? Share feedback.